These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


436 related items for PubMed ID: 26303876

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Guidance for Assessment of Poliovirus Vaccination Status and Vaccination of Children Who Have Received Poliovirus Vaccine Outside the United States.
    Marin M, Patel M, Oberste S, Pallansch MA.
    MMWR Morb Mortal Wkly Rep; 2017 Jan 13; 66(1):23-25. PubMed ID: 28081056
    [Abstract] [Full Text] [Related]

  • 23. Introduction of Inactivated Polio Vaccine, Withdrawal of Type 2 Oral Polio Vaccine, and Routine Immunization Strengthening in the Eastern Mediterranean Region.
    Fahmy K, Hampton LM, Langar H, Patel M, Mir T, Soloman C, Hasman A, Yusuf N, Teleb N.
    J Infect Dis; 2017 Jul 01; 216(suppl_1):S86-S93. PubMed ID: 28838199
    [Abstract] [Full Text] [Related]

  • 24. Anti-polio vaccinations in the third millennia.
    Icardi G, Tassinari F.
    Ann Ig; 2018 Jul 01; 30(4 Supple 1):11-15. PubMed ID: 30062374
    [Abstract] [Full Text] [Related]

  • 25. Trade-offs of different poliovirus vaccine options for outbreak response in the United States and other countries that only use inactivated poliovirus vaccine (IPV) in routine immunization.
    Thompson KM, Kalkowska DA, Kidd SE, Burns CC, Badizadegan K.
    Vaccine; 2024 Feb 06; 42(4):819-827. PubMed ID: 38218668
    [Abstract] [Full Text] [Related]

  • 26. Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of potential non-synchronous cessation.
    Duintjer Tebbens RJ, Hampton LM, Thompson KM.
    BMC Infect Dis; 2016 May 26; 16():231. PubMed ID: 27230071
    [Abstract] [Full Text] [Related]

  • 27. Progress toward poliomyelitis eradication--Nigeria, January 2008-July 2009.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 Oct 23; 58(41):1150-4. PubMed ID: 19847150
    [Abstract] [Full Text] [Related]

  • 28. Intensified Local Resource Mobilization for the Polio Eradication Initiative: The Experience of World Health Organization in Nigeria During 2008-2015.
    Yehualashet YG, Horton J, Mkanda P, Vaz RG, Afolabi O, Gashu SG, Banda R, O'Malley H, Nsubuga P.
    J Infect Dis; 2016 May 01; 213 Suppl 3(Suppl 3):S101-7. PubMed ID: 26912380
    [Abstract] [Full Text] [Related]

  • 29. Contribution of polio eradication initiative to effective new vaccine introduction in Africa, 2010-2015.
    Carole Tevi-Benissan M, Moturi E, Anya BM, Aschalew T, Dicky AB, Nyembo PA, Mbulu LK, Okeibunor J, Mihigo R, Zawaira F.
    Vaccine; 2016 Oct 10; 34(43):5193-5198. PubMed ID: 27396517
    [Abstract] [Full Text] [Related]

  • 30. Progress toward global interruption of wild poliovirus transmission, 2010-2013, and tackling the challenges to complete eradication.
    Wassilak SG, Oberste MS, Tangermann RH, Diop OM, Jafari HS, Armstrong GL.
    J Infect Dis; 2014 Nov 01; 210 Suppl 1(0 1):S5-15. PubMed ID: 25316873
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Addressing the Challenges and Opportunities of the Polio Endgame: Lessons for the Future.
    Patel M, Cochi S.
    J Infect Dis; 2017 Jul 01; 216(suppl_1):S1-S8. PubMed ID: 28838196
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 22.